HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma
Clinical trial NCT02370160 · COMPLETED
Trial details
- NCT number
- NCT02370160
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-21
- Primary completion
- 2018-04-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.